JP2016517691A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016517691A5 JP2016517691A5 JP2016511126A JP2016511126A JP2016517691A5 JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5 JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016511126 A JP2016511126 A JP 2016511126A JP 2016517691 A5 JP2016517691 A5 JP 2016517691A5
- Authority
- JP
- Japan
- Prior art keywords
- chinese hamster
- sequence
- target polypeptide
- expression cassette
- hamster ovary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201308017A GB201308017D0 (en) | 2013-05-03 | 2013-05-03 | Expression process |
| GB1308017.1 | 2013-05-03 | ||
| GB201320339A GB201320339D0 (en) | 2013-11-18 | 2013-11-18 | Expression Process |
| GB1320339.3 | 2013-11-18 | ||
| PCT/GB2014/000165 WO2014177826A1 (en) | 2013-05-03 | 2014-04-29 | Expression process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016517691A JP2016517691A (ja) | 2016-06-20 |
| JP2016517691A5 true JP2016517691A5 (cg-RX-API-DMAC10.html) | 2017-06-08 |
| JP6545153B2 JP6545153B2 (ja) | 2019-07-17 |
Family
ID=50639794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511126A Active JP6545153B2 (ja) | 2013-05-03 | 2014-04-29 | 発現方法 |
Country Status (12)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3323826A1 (en) * | 2016-11-21 | 2018-05-23 | Danmarks Tekniske Universitet | Native chinese hamster ovary cell secretion signal peptides for production of recombinant polypeptides |
| EP3725877A4 (en) | 2017-12-11 | 2021-02-17 | FUJIFILM Corporation | ANIMAL CELLS AS WELL AS A METHOD FOR MANUFACTURING THE SAME, AND A METHOD FOR MANUFACTURING TARGET PROTEIN |
| JP7123168B2 (ja) | 2018-12-11 | 2022-08-22 | 富士フイルム株式会社 | 動物細胞、動物細胞の製造方法および目的タンパク質の製造方法 |
| CN109837277A (zh) * | 2019-03-01 | 2019-06-04 | 深圳生生凡非基因技术有限公司 | 一种cpgk嵌合型启动子、腺相关病毒载体及其应用 |
| JP7352650B2 (ja) | 2019-11-29 | 2023-09-28 | 富士フイルム株式会社 | 細胞培養方法、抗体製造方法、有機酸除去方法、及び、抗体 |
| EP4276167A1 (en) | 2021-01-07 | 2023-11-15 | FUJIFILM Corporation | Cell selection method, device and device system |
| WO2022196710A1 (ja) | 2021-03-17 | 2022-09-22 | 富士フイルム株式会社 | 細胞培養方法、及び有用物質の製造方法 |
| CN112980852B (zh) * | 2021-05-18 | 2021-08-13 | 北京华芢生物技术有限公司 | 新型冠状病毒b.1.351南非突变株rbd的基因及其应用 |
| MX2023014069A (es) | 2021-05-27 | 2024-03-15 | Janssen Biotech Inc | Composiciones y métodos para el tratamiento del cáncer de próstata. |
| WO2023054556A1 (ja) | 2021-09-30 | 2023-04-06 | 富士フイルム株式会社 | 細胞培養方法、及び有用物質の製造方法 |
| CN118541491A (zh) | 2021-12-15 | 2024-08-23 | 富士胶片株式会社 | 产物的制造方法及细胞培养装置 |
| JPWO2023190300A1 (cg-RX-API-DMAC10.html) | 2022-03-28 | 2023-10-05 | ||
| EP4502149A4 (en) | 2022-03-31 | 2026-03-11 | Fujifilm Corp | PRODUCT MANUFACTURING PROCESS AND PRODUCT |
| CN119654417A (zh) | 2022-06-10 | 2025-03-18 | 富士胶片戴奥辛思生物技术英国有限公司 | 细胞的制备方法、异源多聚体蛋白质的制造方法、双特异性抗体的制造方法、载体组、哺乳动物细胞、cho细胞和细胞池的制备方法 |
| JPWO2024071373A1 (cg-RX-API-DMAC10.html) | 2022-09-29 | 2024-04-04 | ||
| JPWO2024248120A1 (cg-RX-API-DMAC10.html) | 2023-05-31 | 2024-12-05 | ||
| EP4722338A1 (en) | 2023-05-31 | 2026-04-08 | FUJIFILM Corporation | Cell culture method and product producing method |
| CN121175432A (zh) | 2023-05-31 | 2025-12-19 | 富士胶片株式会社 | 生产物的生产方法 |
| WO2025244971A1 (en) | 2024-05-20 | 2025-11-27 | Janssen Biotech, Inc. | Compositions and methods for the treatment of prostate cancer |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7071172B2 (en) * | 2002-04-30 | 2006-07-04 | The University Of North Carolina At Chapel Hill | Secretion signal vectors |
| US7186699B2 (en) * | 2003-06-03 | 2007-03-06 | Cell Genesys, Inc. | Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| US8029783B2 (en) * | 2005-02-02 | 2011-10-04 | Genentech, Inc. | DR5 antibodies and articles of manufacture containing same |
| EP1739179A1 (en) * | 2005-06-30 | 2007-01-03 | Octapharma AG | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| GB0602173D0 (en) * | 2006-02-03 | 2006-03-15 | Avecia Ltd | Expression system |
| ES2474940T3 (es) * | 2006-12-28 | 2014-07-10 | Janssen Biotech, Inc. | Métodos y vectores que generan inmunoglobulinas sialiladas |
| KR101618767B1 (ko) * | 2008-09-02 | 2016-05-09 | 한국생명공학연구원 | 외래단백질을 고효율로 생산하는 리더서열 |
| ES2740051T3 (es) * | 2008-12-31 | 2020-02-05 | Bharat Serums & Vaccines Ltd | Anticuerpos monoclonales anti-RHD |
| NZ594514A (en) | 2009-03-05 | 2013-06-28 | Abbott Lab | Interleukin-17 BINDING PROTEINS |
| GB0905331D0 (en) * | 2009-03-27 | 2009-05-13 | Avecia Biolog Ltd | Expression process |
| KR101420274B1 (ko) * | 2011-06-13 | 2014-07-21 | 주식회사 종근당 | Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법 |
-
2014
- 2014-04-29 US US14/787,669 patent/US9873891B2/en active Active
- 2014-04-29 SG SG11201508447TA patent/SG11201508447TA/en unknown
- 2014-04-29 CA CA2910877A patent/CA2910877C/en active Active
- 2014-04-29 EP EP14721474.6A patent/EP2992104B1/en active Active
- 2014-04-29 RU RU2015151626A patent/RU2731717C2/ru active
- 2014-04-29 JP JP2016511126A patent/JP6545153B2/ja active Active
- 2014-04-29 WO PCT/GB2014/000165 patent/WO2014177826A1/en not_active Ceased
- 2014-04-29 KR KR1020157032562A patent/KR102180660B1/ko active Active
- 2014-04-29 ES ES14721474T patent/ES2732907T3/es active Active
- 2014-04-29 DK DK14721474.6T patent/DK2992104T3/da active
- 2014-04-29 CN CN201480024993.4A patent/CN105392889A/zh active Pending
- 2014-04-29 BR BR112015027373A patent/BR112015027373A2/pt not_active Application Discontinuation
- 2014-04-29 CN CN202111508425.XA patent/CN114395584B/zh active Active
-
2017
- 2017-12-12 US US15/838,868 patent/US11306323B2/en active Active
-
2022
- 2022-03-15 US US17/694,760 patent/US20220213500A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015151626A (ru) | Способ экспрессии | |
| PH12020551039A1 (en) | Non-viral dna vectors and uses thereof for antibody and fusion protein production | |
| JP2010536396A5 (cg-RX-API-DMAC10.html) | ||
| HK1207575A1 (en) | Bispecific asymmetric heterodimers comprising anti-cd3 constructs | |
| EA202092093A1 (ru) | Композиции и способы перепрограммирования tcr с применением слитых белков | |
| JP2016104045A5 (cg-RX-API-DMAC10.html) | ||
| IL309975B1 (en) | Anti-c5 antibodies and uses thereof | |
| JP2015529826A5 (cg-RX-API-DMAC10.html) | ||
| JP2015525065A5 (cg-RX-API-DMAC10.html) | ||
| EA202090931A3 (ru) | Композиции и способы перепрограммирования tcr с помощью гибридных белков | |
| RU2018146533A (ru) | Антитела к cd40 и пути их применения | |
| PH12022551580A1 (en) | Anti-ctla-4 antibody and use thereof | |
| CL2016003096A1 (es) | Métodos para cosechar cultivos de células de mamífero | |
| BR112017005245A2 (pt) | animal não humano geneticamente modificado, métodos para produzir célula t, hibridoma de célula t, um ácido nucleico, um anticorpo específico, uma célula humana, um animal não humano geneticamente modificado e para induzir uma resposta imunológica, célula, hibridoma de célula t, ácido nucleico, anticorpo específico, receptor de antígeno quimérico, embrião não humano, locus de um receptor de antígeno quimérico, e, composição de ácidos nucleicos. | |
| JP2014110814A5 (cg-RX-API-DMAC10.html) | ||
| JP2015519055A5 (cg-RX-API-DMAC10.html) | ||
| HK1243333A1 (zh) | 用於修饰的t细胞的方法和组合物 | |
| AR063683A1 (es) | Anticuerpos para il-17a | |
| RU2014118869A (ru) | Мыши с ограниченной тяжелой цепью иммуноглобулина | |
| JP2017538401A5 (cg-RX-API-DMAC10.html) | ||
| HRP20201633T1 (hr) | Protutijela koja se vežu na il-23 | |
| BRPI0812091A2 (pt) | Método para fabricar uma proteína policlonal recombinante | |
| EP4279136A3 (en) | Methods for determining car-t cells dosing | |
| WO2013039996A4 (en) | Compositions and methods for brown fat induction and activity using fndc5 | |
| RU2016136855A (ru) | Биомаркер-направленная многоцелевая иммунотерапия |